Navigation Links
Evaluate Report to Examine Life After the Patent Cliff, Provides Analysis on Pharmaceutical and Biotech Markets and Consensus Forecasts to 2018
Date:6/13/2013

LONDON and BOSTON, June 13, 2013 /PRNewswire/ --

Patent expirations in 2012 have put the industry through an unprecedented decline in worldwide prescription drug sales in 2012. Now that the pharmaceutical industry has faced the biggest patent cliff it has ever seen, Evaluate Ltd. will examine its effects and what the industry can expect through 2018 in its upcoming annual World Preview report. Evaluate will release the report, which is based on EvaluatePharma® data, on Monday, June 24 in conjunction with the DIA 2013 49th Annual Meeting in Boston, MA.

The EvaluatePharma World Preview 2013 Edition will include:

  • Worldwide prescription and generic drug sales through 2018
  • Sales at risk due to patent expirations through 2018
  • Sales by therapy area through 2018
  • Global pharmaceutical R&D spend
  • FDA new drug approval analysis
  • Top grossing companies and products by market
  • M&A and venture funding analysis

For more information on the 2013 Edition of the World Preview report and to receive your complimentary copy of the Executive Summary, please visit the Evaluate booth #630 at DIA. The summary and full report will be available on the Evaluate web site beginning June 24, 2013. Follow @evaluatepharma on Twitter for a reminder.

If you are attending the 2013 DIA Annual Meeting or the EphMRA 2013 conference and would like to meet, please Contact Us.

About Evaluate Ltd.

Established in 1996, Evaluate Ltd. is the leader in high quality life science sector analysis.

SOURCE Evaluate Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Marketing Services Groups Face Constant Pressure to Evaluate and Evolve their Organization
2. Inovalon Partners with Pharmacy Quality Alliance to Evaluate Medication Adherence Quality Performance Measure
3. Soligenix Receives IND Clearance from FDA to Initiate Clinical Program to Evaluate SGX942 for the Treatment of Oral Mucositis
4. Trovagene and Barretos Cancer Hospital, Brazil, to Evaluate Urine-Based HPV Assay as Potential Pap Smear Replacement
5. Avaxia Biologics Receives IND Clearance from FDA to Initiate Clinical Program to Evaluate AVX-470 as Therapy for Ulcerative Colitis
6. Study Published In Contraception Evaluates Medical Expenditures For Unintended Pregnancies And Potential Cost Impact Of Increased Use Of Long-Acting Reversible Contraception
7. EvaluatePharma Appoints Alexander Karle as COO
8. Terumo Completes U.S. Patient Enrollment in the OSPREY Trial to Evaluate the MISAGO Self-expanding Stent
9. Researchers Evaluate Computer-based Treatment for People with Schizophrenia
10. EvaluatePharma Names Debbie Paul CEO, Americas to Lead Growth in Key Region
11. U.S. News & World Report Honors 7 SynCardia Certified Centers Among "Best Childrens Hospitals" for Cardiology and Heart Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 19, 2014  Monarch America Inc. ... Kinetics Corp.) is pleased to provide this review of ... growth in 2015. "Over this past year, ... and I am extremely proud to say that Monarch ... today than it has ever been," stated Eric ...
(Date:12/19/2014)... , Dec. 18, 2014 Somewhere between ... hearing health was forgotten. But Audicus , a ... hear better this new year. Hearing loss ... the aging population, though it is often unaddressed. Forty-eight ... four has a hearing aid, mainly due to price. ...
(Date:12/19/2014)... -- Decision Resources Group finds that the laparoscopic device market ... increase to a value of over $4.3 billion by ... the large direct energy device market. In particular, premium-priced ... to the advantages they offer and as new products ... Resources Group,s coverage of the U.S. laparoscopic device market: ...
Breaking Medicine Technology:Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 3Audicus Will Help People Resolve to Hear Better in 2015 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 3
... Pa., May 25, 2011 A study titled ... published in the May 26 issue of ... prostate cancer who have received prior chemotherapy containing ... when treated with ZYTIGA ™ (abiraterone acetate) ...
... (NASDAQ: ITMN ) will outline the company,s corporate ... ongoing plans to commercialize Esbriet ® (pirfenidone) in Europe, ... pirfenidone study, during a meeting with analysts in New York ... the presentations beginning at 8:30 a.m. EDT.   ...
Cached Medicine Technology:Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 2Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 3Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 4Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 5Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 6InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study 2InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study 3InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study 4InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study 5InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study 6
(Date:12/22/2014)... December 22, 2014 The Bob ... ever, having invested more than $5 million in ... veterans and their families. , This includes $1.3 ... dozen nonprofits, helping with: veteran entrepreneurship; community impact; ... life-coaches for severely injured veterans. , “The needs ...
(Date:12/22/2014)... 2014 Give a loved one the ... of health and vitality. , For a limited time, ... anti-aging formulas in special Holiday Wellness gift packages at ... , Each bottle contains cutting-edge, proven nutritional support for ... as well as we age. , Joint ...
(Date:12/22/2014)... 22, 2014 Xarelto Lawsuit News ... of judges has granted a request to centralize pending ... District Court, Eastern District of Louisiana. The U.S. Judicial ... December 12 to transfer over 50 Xarelto cases–21 lawsuits ... the Louisiana court for consolidation under U.S. District Judge ...
(Date:12/22/2014)... St. Petersburg, FL (PRWEB) December 22, 2014 ... needed. Sublime Beauty® has a fast and easy solution that ... online gift cards can be purchased from from $25 up ... ®. "We offer 100% customer satisfaction and a wide array ... cards have no fees and no expiration dates. , ...
(Date:12/22/2014)... December 22, 2014 The ... professional development programs this month. Faculty have been ... on nurse educators fast-tracked for administrative leadership roles ... Development Program for Simulation Educators, featuring a curriculum ... of nursing education. , Twenty nurse educators ...
Breaking Medicine News(10 mins):Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 2Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 3Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 4Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 5Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 6Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 7Health News:You Still Have Time to Give the Gift of Health and Vitality to a Mature Loved One 2Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 2Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 3Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 4Health News:NLN Leadership Institute Announces 2015 Cohorts 2Health News:NLN Leadership Institute Announces 2015 Cohorts 3
... is marking its first National Women and Girls HIV/AIDS ... Fauci, MD, director of the National Institute of Allergy ... Health (NIH) // said in a press release, “This ... increasing impact of HIV/AIDS on women and girls in ...
... a zone in Torun, in northern Poland on the bank of ... Polish vets confirmed the presence of the H5N1 bird flu virus ... the German border but the vets did not confirm whether the ... put by Tadeusz Wijaszka, director of the national laboratory in Pulawy, ...
... passage, which results due to smoking is said to ... ,Called Chronic Obstructive Pulmonary Disease (COPD), ... and emphysema of the lungs. ,Unlike simple ... the mucous membrane and emphysema decomposes lung tissue. People ...
... breast cancer victims is denied by the NHS to victims ... private medical insurers have saved their day by pitching in. ... available this drug to almost 100 women, who have been ... the drug available in 30 such cases. ,It ...
... favor of the rise in Medicare bulk billing, which is ... Health Minister Tony Abbott released some alarming statistics that show ... ,According to Dr Kim Bulwinkel, from AMA Queensland, ... more patients, in order to make it a feasible option. ...
... that the risk of the H5N1 strain reaching Australia was ... the French parliamentary commission on the disease and put the ... ,It said that the avian flu was likely to ... chief vet Gardner Murray has rejected the world animal health ...
Cached Medicine News:
...
Lacrimal Cannula, Straight, Stepped DownSize: 19g x 1-1/2"....
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Medicine Products: